John Kevin Teladoc Well being (NYSE:TDOC) is scheduled to announce Q3 financials for 2023 on Tuesday, October 24, after the market shut, whereas its traders await one other earnings beat from the telehealth supplier. Buy, New York-headquartered Teladoc (TDOC) has surpassed expectations for quarterly earnings for 2 years in a row, whereas its income has …
John Kevin
Teladoc Well being (NYSE:TDOC) is scheduled to announce Q3 financials for 2023 on Tuesday, October 24, after the market shut, whereas its traders await one other earnings beat from the telehealth supplier.
Buy, New York-headquartered Teladoc (TDOC) has surpassed expectations for quarterly earnings for 2 years in a row, whereas its income has topped forecasts for 4 consecutive quarters. It has overwhelmed quarterly income estimates 88% of the time over the previous two years.
The consensus EPS estimate for the corporate’s third quarter is -$0.37 (+12% Y/Y), and its consensus income estimate stands at $663.1M (+8% Y/Y).
During the last three months, Wall Avenue has boosted the projections for the corporate’s upcoming earnings 3 times, with just one downward revision. Income estimates have seen 11 upward and downward revisions every.
Q3 was a comparatively quiet interval for Teladoc (TDOC). The pandemic-era favourite noticed its inventory greater than double in worth in 2020 as sufferers flocked to telehealth providers amid COVID-driven issues about social interactions.
Nonetheless, TDOC shares surged in July after the corporate lifted its full-year earnings and income steerage to -$1.60 loss per share and $2.6B-$2.675B, from -$1.70-$1.25 and $2.575B-2.675B, respectively.
Keep in touch with our news & offers
